Analysis of EVs of TKI-resistant cancer cells as well as plasma of patients with TKI-resistant metastatic cancer reveal an enrichment in SLC1A5 and SLC25A5 solute carrier transporters and ALDHA1. This evidence concerns the gene SLC1A5 and cancer.